(Q44369816)

2 December 2017

title

Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma (English)

1 reference

2 December 2017

main subject

phase III clinical trial

0 references

author name string

Mornex F

1

1 reference

2 December 2017

Thomas L

2

1 reference

2 December 2017

Mohr P

3

1 reference

2 December 2017

Hauschild A

4

1 reference

2 December 2017

Delaunay MM

5

1 reference

2 December 2017

Lesimple T

6

1 reference

2 December 2017

Tilgen W

7

1 reference

2 December 2017

Nguyen BB

8

1 reference

2 December 2017

Guillot B

9

1 reference

2 December 2017

Ulrich J

10

1 reference

2 December 2017

Bourdin S

11

1 reference

2 December 2017

Mousseau M

12

1 reference

2 December 2017

Cupissol D

13

1 reference

2 December 2017

Bonneterre J

14

1 reference

2 December 2017

de Gislain C

15

1 reference

2 December 2017

Bensadoun JR

16

1 reference

2 December 2017

Clavel M

17

1 reference

2 December 2017

publication date

1 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

7

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

1-8

1 reference

Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: report on a pilot study.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation Therapy Oncology Group Brain Metastases Study I and II

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Cerebral metastases of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Demographics of brain metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Fotemustine in the treatment of brain primary tumors and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Positive phase II study in the treatment of advanced malignant melanoma with fotemustine

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Cerebral metastases from malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Radiation Therapy for Brain Metastases from Malignant Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

Management of cerebral metastases from malignant melanoma: results of a combined, simultaneous treatment with fotemustine and irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2802%2900284-6

7 January 2021

10.1016/S1278-3218(02)00284-6

Identifiers

DOI

1 reference

2 December 2017

1 reference